Výsledky vyhledávání

Akademický článek

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Autor: Gammelgaard OL; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark. ogammelgaard@health.sdu.dk., Terp MG; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark., Kirkin AF; Cytovac A/S, 2970, Hørsholm, Denmark., Johansen S; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark., Traynor S; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark., Vever H; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark., Guldberg P; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark.; Danish Cancer Institute (DCI), Copenhagen, Denmark., Kodahl AR; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Gjerstorff MF; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark.; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 5000, Odense C, Denmark. hditzel@health.sdu.dk.; Department of Oncology, Odense University Hospital, Odense, Denmark. hditzel@health.sdu.dk.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. hditzel@health.sdu.dk.; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark. hditzel@health.sdu.dk.

Publikováno v: Molecular cancer [Mol Cancer] 2024 Jan 06; Vol. 23 (1), pp. 6. Date of Electronic Publication: 2024 Jan 06.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma.

Autor: Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Stragliotto G; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden., Strandeus M; Department of Oncology, Ryhov Hospital, Jönköping, Sweden., Blomstrand M; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Carén H; Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Jakola AS; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Rydenhag B; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Dyregaard D; Cytovac A/S, Hørsholm, Denmark., Dzhandzhugazyan KN; Cytovac A/S, Hørsholm, Denmark., Kirkin AF; Cytovac A/S, Hørsholm, Denmark., Raida MK; Cytovac A/S, Hørsholm, Denmark., Smits A; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden., Kinhult S; Department of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2021 Oct 22; Vol. 3 (1), pp. vdab156. Date of Electronic Publication: 2021 Oct 22 (Print Publication: 2021).

Zobrazit plný text záznamu

Akademický článek

Adoptive T cell cancer therapy.

Autor: Dzhandzhugazyan KN; Danish Cancer Society Research Center, Copenhagen, Denmark.; CytoVac A/S, Hørsholm, Denmark., Guldberg P; Danish Cancer Society Research Center, Copenhagen, Denmark., Kirkin AF; Danish Cancer Society Research Center, Copenhagen, Denmark. aki@cancer.dk.; CytoVac A/S, Hørsholm, Denmark. aki@cancer.dk.

Publikováno v: Nature materials [Nat Mater] 2018 Jun; Vol. 17 (6), pp. 475-477.

Zobrazit plný text záznamu

Akademický článek

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Autor: Kirkin AF; Danish Cancer Society Research Center, 2100, Copenhagen, Denmark. aki@cytovac.dk.; CytoVac A/S, 2970, Hørsholm, Denmark. aki@cytovac.dk., Dzhandzhugazyan KN; Danish Cancer Society Research Center, 2100, Copenhagen, Denmark.; CytoVac A/S, 2970, Hørsholm, Denmark., Guldberg P; Danish Cancer Society Research Center, 2100, Copenhagen, Denmark., Fang JJ; Danish Cancer Society Research Center, 2100, Copenhagen, Denmark.; CytoVac A/S, 2970, Hørsholm, Denmark., Andersen RS; Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark., Dahl C; Danish Cancer Society Research Center, 2100, Copenhagen, Denmark., Mortensen J; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark., Lundby T; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark., Wagner A; Department of Neuroradiology, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark., Law I; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark., Broholm H; Department of Neuropathology, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark., Madsen L; Department of Pathology, Aarhus University Hospital, 8000, Aarhus, Denmark., Lundell-Ek C; CytoVac A/S, 2970, Hørsholm, Denmark., Gjerstorff MF; Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark., Ditzel HJ; Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark.; Department of Oncology, Odense University Hospital, 5000, Odense, Denmark., Jensen MR; CytoVac A/S, 2970, Hørsholm, Denmark., Fischer W; CytoVac A/S, 2970, Hørsholm, Denmark.; Department of Neurosurgery, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark.

Publikováno v: Nature communications [Nat Commun] 2018 Mar 06; Vol. 9 (1), pp. 785. Date of Electronic Publication: 2018 Mar 06.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání